TD Asset Management »

Generate Biomedicines Ord shares owned by TD Asset Management

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $536k 43k 12.50

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Cibc Cad (CM)
Broadcom (AVGO)
Agnico (AEM)
Canadian Natural Resources (CNQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Suncor Energy (SU)
Amazon (AMZN)

View all positions for TD Asset Management

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
Capital World Investors
Braidwell
Arch Venture Corp
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Morgan Stanley
ExodusPoint Capital Management
CenterBook Partners
Sphera Funds Management

View all funds holding Generate Biomedicines Ord